Retro develops therapies for diseases driven by the biology of aging. We take pride in cultivating an environment that fosters collaboration, open communication, and authenticity.
Retro develops therapies for diseases driven by the biology of aging. We are building a mission-driven, collaborative team operating with speed, transparency, and adaptability. We are hiring a new member of the team who will lead analytical development and product quality strategy for RTR242, a small molecule in Phase I for the treatment of neurodegenerative diseases such as Alzheimer’s.
Retro develops therapies for diseases driven by the biology of aging. We take pride in cultivating an environment that fosters collaboration, open communication, and authenticity.
Neurocrine Biosciences